anonymous
Guest
anonymous
Guest
starting to hear some hospitals being approached about Senhance.. any feedback about this robot? Have heard mixed reviews from my surgeons who have tried it
They are hiring a US sales force now.
Not heard a whole lot about it other than it is reusable instrumentation and costs around $350.00 per case to operate. The system is about 1.4m
Indications are in GYN / General / Colorectal for now..........
starting to hear some hospitals being approached about Senhance.. any feedback about this robot? Have heard mixed reviews from my surgeons who have tried it
Just heard from an account who is trying to leverage Transenterix against Intuitive that they are lowering their price to under $1m for the purchase of the Senhance. That’s a 500k price drop.
IMO this tactic is smart but also too late. This is a sign that the end is coming for this company.
Good thing for me doctors still choose the best clinical options, at least most of them do.
Really?
How about this recent sales in Germany? SH was sold for $2.2mil.
Also, in Japan SH was just approved for broader indication than DV. That's telling!
It's just a matter of time before SH starts eating DV's market share in the US.
You want real feedback. Just ask the General Surgeons who do have the Senhance at their accounts.
These are the accounts that have purchased, LSU, Florida Hospital, Pascack Valley, and UPMC. These are the accounts that use Senhance but are not buying, Flagler, and Buffalo. This honestly says it all.
Fantasy time is over.
Really?
How about this recent sales in Germany? SH was sold for $2.2mil.
Also, in Japan SH was just approved for broader indication than DV. That's telling!
It's just a matter of time before SH starts eating DV's market share in the US.
Haptic feedback? LOL.. not nearly as impressive as it was with my PlayStation 1 20 something years ago.Haptic feedback, eye tracking, 3mm instruments, reusable instruments, and much more.
Senhance Experience at Pascack Valley Medical Center - Hackensack, NJ, USA
Haptic feedback? LOL.. not nearly as impressive as it was with my PlayStation 1 20 something years ago.
Put the marketing piece down.
Regarding Hackensack, ask the Chairman of Surgery, the Director of Robotics, Dr Michael Stifleman, and the Dr Pereira, Chief of Surgery what they think of the Senhance.
Tomorrow’s Earnings Report will clear up all the nonsense you are spouting.
Really?
How about this recent sales in Germany? SH was sold for $2.2mil.
Also, in Japan SH was just approved for broader indication than DV. That's telling!
It's just a matter of time before SH starts eating DV's market share in the US.
Haptic feedback? LOL.. not nearly as impressive as it was with my PlayStation 1 20 something years ago.
Put the marketing piece down.
Regarding Hackensack, ask the Chairman of Surgery, the Director of Robotics, Dr Michael Stifleman, and the Dr Pereira, Chief of Surgery what they think of the Senhance.
Tomorrow’s Earnings Report will clear up all the nonsense you are spouting.
DV is garbage with lots of issues. The monopoly is over.
http://ir.transenterix.com/news-rel...inc-reports-operating-and-financial-results-0
Honestly do I have to say anything else.
Ok. I will.
-2 robot sales YTD Global
1 sale globally this quarter
-0 US sales YTD. Last sale back in November.
- Transenterix pulling back FDA submission on articulation. (This is actually the worse news) what!?!?!?!
- Trxc will not provide guidance anymore during ER
- stock is .80 down from 6.00 a yr ago
- TRXC has enough working capital to last only through mid 2020
-LMFAO!!!
I’m sorry you had something to say?
I could say get off this board and go sell a robot, but instead you should be looking for a job.
DV is garbage with lots of issues. The monopoly is over.
This Surgical Robot Promises A Quicker Recovery, But There Are Risks | NBC Nightly News
DV is garbage with lots of issues. The monopoly is over.
This Surgical Robot Promises A Quicker Recovery, But There Are Risks | NBC Nightly News